LA JOLLA, CA, April 30, 2024 – Enlaza Therapeutics, the first covalent biologic platform company, today announced a $100 million Series A financing. The financing will be used to further...
Art Pappas will participate on a panel titled "Life Sciences Incubation Models" at the International Association of Research Parks World Conference in Raleigh, NC
News | 06. 04. 2009
© 2024 Pappas Capital, LLC. ALL RIGHTS RESERVED.